NCT06697561

Brief Summary

The purpose of this study is to develop an evidence-based educational program for scleroderma patients with hand dysfunction. The program includes a self-care handbook and multimedia video resources. The study aims to answer: Does the intervention improve hand function in the experimental group compared to the control group? Does the intervention improve self-care knowledge of hand dysfunction? Does the intervention improve overall health? Participants will receive an 8-week program, while the control group receives usual care. Outcome measures include hand function, overall health, and self-care knowledge.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

11 months

First QC Date

November 16, 2024

Last Update Submit

November 19, 2024

Conditions

Keywords

SclerodermaHand dysfunctionEvidence-based knowledge translationPatient education

Outcome Measures

Primary Outcomes (5)

  • Self-developed questionnaire on self-care knowledge for scleroderma hand dysfunction

    The "Scleroderma Hand Function-Related Self-Care Knowledge Scale," validated by experts for reliability and validity, consists of 15 items. The scale uses a dichotomous scoring method with three response options: "True," "False," and "Don't know." It includes both positively and negatively worded items. Correct answers are scored as one point, while incorrect answers and "Don't know" responses are scored as zero. The total score ranges from 0 to 15, with higher scores indicating a greater level of self-care knowledge regarding scleroderma-related hand function impairments.

    At baseline, 4 weeks, and 8 weeks post-intervention

  • Grip strength

    Grip strength of the dominant hand (in kg) will be measured using a dynamometer, and the average of three trials will be used as the final muscle strength assessment indicator.

    At baseline, 4 weeks, and 8 weeks post-intervention.

  • delta finger-to-palm, Delta-FTP

    Delta-FTP refers to the difference in distance between the tip of the third finger and the midpoint of the distal palmar crease when the finger is fully extended and fully flexed. It is an effective measurement method to assess the range of motion and flexibility of fingers in patients with scleroderma.

    At baseline, 4 weeks, and 8 weeks post-intervention.

  • Raynaud's phenomenon visual analog scale

    This scale evaluates the severity and impact of Raynaud's phenomenon on daily activities in patients with scleroderma over the past week. Scores range from 0 mm (no impact) to 100 mm (very severe impact), with higher scores indicating greater impairment of hand function

    At baseline, 4 weeks, and 8 weeks post-intervention.

  • Digital ulcers visual analog scale

    This scale evaluates the severity and impact of Digital ulcers on daily activities in patients with scleroderma over the past week. Scores range from 0 mm (no impact) to 100 mm (very severe impact), with higher scores indicating greater impairment of hand function.

    At baseline, 4 weeks, and 8 weeks post-intervention.

Secondary Outcomes (2)

  • Overall disease severity visual analog scale

    At baseline, 4 weeks, and 8 weeks post-intervention

  • Adherence to Hand Exercise Training

    At baseline, 4 weeks, and 8 weeks post-intervention.

Study Arms (2)

Patient education group

EXPERIMENTAL

receives the "Evidence-Based Education Program for people with hand dysfunction in scleroderma" (which includes: educational handbook on self-care for hand dysfunction in scleroderma, multimedia teaching materials, and individualized consultations).

Behavioral: patient education program

control group

NO INTERVENTION

Receives usual care

Interventions

The intervention for the experimental group was an "evidence-based educational program for hand dysfunction in patients with systemic sclerosis," which included a health education manual and multimedia videos developed through evidence translation. Additionally, individual education and consultation were provided.

Patient education group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants with systemic sclerosis who meet the 2013 American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) diagnostic criteria and have hand dysfunction.
  • Adults aged 18 years or older.
  • Participants who are conscious and able to communicate in Mandarin Chinese or Taiwanese Hokkien.
  • Participants who provide informed consent to participate in the study after being briefed on its purpose.

You may not qualify if:

  • \. Participants who have participated in any other hand rehabilitation program within the past three months.
  • , Participants with organic brain dysfunction. 3. Participants with severe visual or hearing impairments. 4. Participants with serious illnesses that hinder communication or interfere with the normal learning process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cheng Hsin General Hospital

Taipei, 112, Taiwan

Location

MeSH Terms

Conditions

Scleroderma, SystemicScleroderma, Diffuse

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • Cheng Hsin General Hospital

    Institutional Review Board

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Nurse Practitioner

Study Record Dates

First Submitted

November 16, 2024

First Posted

November 20, 2024

Study Start

July 30, 2024

Primary Completion

June 30, 2025

Study Completion

July 31, 2025

Last Updated

November 20, 2024

Record last verified: 2024-11

Locations